(MD+DI) – An industry analyst expects Zimmer Biomet’s Rosa Knee robotic system to represent a formidable competitor to Stryker’s Mako Knee after the Rosa Knee’s full launch later this year. However, both Mako and Rosa have their strengths and weaknesses, and neither is clearly superior, the analyst said. […]
(Financial Times) – When Namal Nawana was wooed to take the top job at Smith & Nephew, he took a hard look at the venerable UK medical devices company and found both a puzzle and an opportunity. […]
(MassDevice) – Stryker’s success with its Mako robot-assisted surgery platform has other orthopedic device companies hastening to enter the space. The big question is whether long-term outcomes will justify the expensive technology. […]
(MD+DI) – Zimmer Biomet’s revenue growth is expected to accelerate during 2019 as the company shifts back to offense after addressing supply issues that have plagued the orthopedic device maker since 2016. […]
(Motley Fool) – J&J’s latest acquisition might appear to threaten its partnership with Alphabet to develop robotic surgical systems. But another player could be affected even more. […]
(MD+DI) – After spending 2018 dealing with quality control remediation and supply chain issues, Zimmer Biomet expects to return to market growth by 2020. […]
Copyright © 2019 | MH Magazine WordPress Theme by MH Themes